New Research from the CWMH: Data on the Reproductive Safety of Vortioxetine
New prospective data on 56 first-trimester vortioxetine exposures found no major malformations, offering reassuring but still preliminary reproductive safety information.
New Research from the CWMH: Data on the Reproductive Safety of Cariprazine
New registry data found no major malformations among 58 infants exposed to cariprazine in the first trimester, offering reassuring but preliminary reproductive safety evidence.
A Message from the MGH Postpartum Psychosis Project This Maternal Mental Health Month
The Postpartum Psychosis Project team shares what inspires their work and the key lessons they hope more people understand.
Recruiting for Research Study: THRIVE (Targeting Health and Resilience for Individuals with a Vulnerable Eating History)
Do you have a history of an eating disorder or eating problems and are currently in your first or second trimester of pregnancy?
Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
Recruiting for Research Study: Pregnenolone Neurosteroid for Menopausal Depression
As of October 2023, the Neurosteroid Intervention for Menopausal and Perimenopausal Depression is no longer recruiting participants. Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids. [...]
New Research from the CWMH: More Data on the Reproductive Safety of Lurasidone and Quetiapine
New findings from the National Pregnancy Registry for Atypical Antipsychotics provide reassuring data regarding the safety of prenatal exposure to lurasidone and quetiapine in a sample of well-characterized participants.
New Research at the Center for Women’s Mental Health: The MGH Postpartum Psychosis Project
Although the last decade has brought increased awareness of and interest in postpartum mood and anxiety disorders, our understanding of the etiology of this most severe form of postpartum mental illness remains elusive.
New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine
No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.